Background—The prognostic usefulness of troponin enzymes in end-stage renal disease
(ESRD) patients is controversial. To resolve this uncertainty of troponin as a prognostic tool …

Background: Clinicians face uncertainty about the prognostic value of troponin testing in
patients with chronic kidney disease (CKD) without suspected acute coronary syndrome …

Primary systemic amyloidosis (AL) is a fatal plasma cell disorder. Pilot data suggest survival
is better in patients undergoing peripheral blood stem cell transplantation (PBSCT), but the …

Despite the frequency of cardiovascular death in dialysis patients, few studies have
prospectively measured sudden cardiac death in these individuals. Here, we sought to …

It is well recognized that the procedure of hemodialysis is associated with significant
changes in blood pressure and systemic hemodynamics; 20–30% of treatments are …

BACKGROUND: Although the cardiac biomarker troponin T (cTnT) is related strongly to
mortality in patients with end-stage renal disease, the independent association of N-terminal …

Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients with all
forms of chronic kidney disease (CKD). The underlying pathological state is caused by a …

Results During a median follow-up of 2.5 years, 808 patients died. Rates of SCD, non-SCD,
and noncardiac death were 22%, 17%, and 61%, respectively. Predictors of various causes …

Abstract Background: S100A12, also known as EN-RAGE (extracellular newly identified
receptor for advanced glycation end products binding protein) is a ligand for RAGE, and has …

Presentation and Outcome of Patients with Systemic Amyloidos... : Clinical Journal of the
American Society of Nephrology Presentation and Outcome of Patients with Systemic …